Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 1, 1995
Recent developments in the neuropharmacology of schizophrenia
A C Lahti, C A Tamminga
The American Journal of Psychiatry
|
November 14, 1997
Images in neuroscience. Clinical genetics, V. Association of genetic and personality characteristics
R A Lahti, A C Lahti
Dialogues in Clinical Neuroscience
|
October 29, 2011
Treatments for chronic psychosis
C A Tamminga, A C Lahti
International Clinical Psychopharmacology
|
May 1, 1996
The new generation of antipsychotic drugs
C A Tamminga, A C Lahti
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 8, 2014
Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response
K A Barksdale, A C Lahti, Rosalinda C Roberts
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1995
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
A C Lahti, B Koffel, D LaPorte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 24, 1998
Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia
A C Lahti, M Weiler, A Carlsson, et al.
Journal of Psychiatric Research
|
September 1, 1996
Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients
D J LaPorte, A C Lahti, B Koffel, et al.
Hippocampus
|
December 6, 2001
Probing the human hippocampus using rCBF: contrasts in schizophrenia
D R Medoff, H H Holcomb, A C Lahti, et al.
Schizophrenia Research
|
July 27, 2015
Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia
R C Roberts, K A Barksdale, J K Roche, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 1, 1995
Recent developments in the neuropharmacology of schizophrenia
A C Lahti, C A Tamminga
The American Journal of Psychiatry
|
November 14, 1997
Images in neuroscience. Clinical genetics, V. Association of genetic and personality characteristics
R A Lahti, A C Lahti
Dialogues in Clinical Neuroscience
|
October 29, 2011
Treatments for chronic psychosis
C A Tamminga, A C Lahti
International Clinical Psychopharmacology
|
May 1, 1996
The new generation of antipsychotic drugs
C A Tamminga, A C Lahti
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 8, 2014
Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response
K A Barksdale, A C Lahti, Rosalinda C Roberts
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 1, 1995
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
A C Lahti, B Koffel, D LaPorte, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 24, 1998
Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia
A C Lahti, M Weiler, A Carlsson, et al.
Journal of Psychiatric Research
|
September 1, 1996
Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients
D J LaPorte, A C Lahti, B Koffel, et al.
Hippocampus
|
December 6, 2001
Probing the human hippocampus using rCBF: contrasts in schizophrenia
D R Medoff, H H Holcomb, A C Lahti, et al.
Schizophrenia Research
|
July 27, 2015
Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia
R C Roberts, K A Barksdale, J K Roche, et al.
Page
of 4